Structure Therapeutics (GPCR) Non-Current Assets (2022 - 2026)

Structure Therapeutics' Non-Current Assets history runs 5 years deep, the most recent figure standing at $17.5 million for Q1 2026.

• In Q1 2026, Non-Current Assets rose 3.54% year-over-year to $17.5 million; the TTM figure through Mar 2026 stood at $66.4 million (up 38.32% YoY), while the FY2025 annual figure was $13.6 million, up 12.34% from the prior year.
• Non-Current Assets was $17.5 million for Q1 2026 at Structure Therapeutics, up from $13.6 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $18.1 million in Q3 2025 to a low of $1.2 million in Q1 2023.
• Historically, Non-Current Assets has averaged $10.3 million across 5 years, with a median of $9.5 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Non-Current Assets soared 680.1% in 2024, then gained 3.54% in 2026.
• A 5-year view of Non-Current Assets shows it stood at $4.8 million in 2022, then surged by 76.81% to $8.4 million in 2023, then surged by 44.12% to $12.1 million in 2024, then grew by 12.34% to $13.6 million in 2025, then gained by 28.73% to $17.5 million in 2026.
• The last three Non-Current Assets figures came in at $17.5 million (Q1 2026), $13.6 million (Q4 2025), and $18.1 million (Q3 2025), per Business Quant data.